A new study may pave the way toward more personalized treatments for patients with high-risk bladder cancer, according to a study published in European Urology.

A new survey undertaken by the Harris Poll for Johnson & Johnson has shown how standard forms of surgery and treatment for ...

Add Yahoo as a preferred source to see more of our stories on Google. How does bladder cancer develop and what are the most common causes? In the last couple of years, Professor Syed Hussain has ...

Patrick Hensley, MD and Daniel Joyce, MD, MS each received a grant up to $50,000.00 to support the development of outstanding clinical cancer ...

Editor's Note: This is an excerpt from WBUR's weekly health newsletter, CommonHealth. If you like what you read and want it in your inbox, sign up here. Bladder cancer hits men especially hard. The ...

IBRX secures five U.S. patents for Anktiva in bladder cancer, extending franchise protection through 2035 amid strong sales ...

The FDA will review the expansion of Anktiva plus BCG to patients with papillary-only bladder cancer, with a final decision expected by Jan.6, 2027. ・The acceptance reversed last year’s FDA refusal-to ...

Discover the 3 Best-Performing Biotech IPO Stocks of 2024 CG Oncology (NASDAQ:CGON) executives used an RBC Capital Markets ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

But when Jimi began experiencing bladder cancer symptoms, including blood in his urine, he felt a different kind of rush. It was the kind that puts you into shock. “Cancer was definitely something ...